This study aims to assess the quality of current Barrett’s Oesophagus surveillance delivery against a dedicated service in the post BSG guideline era.Methods
All patients undergoing BO surveillance between January 2016 and July 2017 at a single NHS district general hospital (DGH) were included. Patients had their endoscopy conducted on a dedicated BO endoscopy list or a generic service list. Data were collected prospectively against the BSG guidelines. Prospective surveillance data were also compared to each patient’s prior surveillance endoscopy experience.Results
361 patients were scheduled for surveillance of which 217 attended a dedicated list (29 discharged, 13.4%), 78 attended a non-dedicated list (7 discharged, 9%) and 66 did not have their endoscopy. The cohorts were comparable in terms of age, sex and co-morbidity prevalence. The dedicated list adhered more closely to the BSG guidelines (table 1). Histology results from the dedicated list cohort revealed higher rates of intestinal metaplasia (79.8% vs 73.1%, p=0.1155) and dysplasia/OAC (4.3% vs 2.6%, p=0.4082) when compared to the non-dedicated, although statistical significance was not reached.Conclusions
The post-BSG guideline era of BO surveillance remains suboptimal in this DGH. A dedicated service can improve the accuracy and consistency of surveillance care pathways in line with current best practice, although the clinical significance of this remains to be determined.